Dundas Partners LLP Purchases 2,029 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Dundas Partners LLP increased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 24.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,254 shares of the company’s stock after buying an additional 2,029 shares during the period. Dundas Partners LLP’s holdings in Ryan Specialty were worth $658,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new stake in Ryan Specialty in the fourth quarter worth approximately $94,484,000. Principal Financial Group Inc. grew its holdings in Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock valued at $117,619,000 after buying an additional 981,505 shares in the last quarter. Jennison Associates LLC grew its position in shares of Ryan Specialty by 60.2% during the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after purchasing an additional 385,366 shares in the last quarter. Eagle Asset Management Inc. increased its position in Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after purchasing an additional 335,180 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Ryan Specialty by 43.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after purchasing an additional 286,380 shares during the period. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Stock Up 0.1 %

Shares of Ryan Specialty stock opened at $69.31 on Friday. The stock has a market cap of $18.15 billion, a price-to-earnings ratio of 100.45, a PEG ratio of 1.19 and a beta of 0.71. The firm’s 50-day moving average is $66.57 and its two-hundred day moving average is $67.59. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be issued a dividend of $0.12 per share. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.69%. Ryan Specialty’s payout ratio is 69.57%.

Analysts Set New Price Targets

RYAN has been the topic of several recent analyst reports. Barclays increased their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. UBS Group increased their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Wells Fargo & Company increased their price target on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday, February 21st. Finally, Royal Bank of Canada dropped their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. According to MarketBeat, Ryan Specialty has an average rating of “Hold” and an average target price of $75.27.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00. Following the completion of the transaction, the director now owns 65,100 shares of the company’s stock, valued at approximately $4,387,089. This represents a 34.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold 316,451 shares of company stock worth $20,907,793 over the last three months. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.